Replacement of Principal Investigator Sample Clauses

Replacement of Principal Investigator. In the event the Principal Investigator becomes either unwilling or unable to perform the duties required by this Agreement Institution shall notify Sponsor in writing within ten (10) days, and Institution and Principal Investigator will cooperate, in good faith and expeditiously, to find a replacement investigator acceptable to Sponsor. In the event an acceptable substitute is not found, this Agreement may be terminated by Sponsor in accordance with Section 11 of this Agreement. Institution’s cooperation in finding an acceptable replacement investigator does not modify or alter its obligation to perform its obligations and duties pursuant to this Agreement. In the event of continuation, the substitute principal investigator shall sign documentation provided by Sponsor acknowledging his or her new duties as Principal Investigator.
Sample 1Sample 2See All (7)
AutoNDA by SimpleDocs
Replacement of Principal Investigator. In the event that the Principal Investigator is unwilling or unable to perform his or her duties hereunder, Licensor shall promptly appoint a successor mutually agreeable to the parties.
Sample 1Sample 2Sample 3See All (4)
Replacement of Principal Investigator. If the Principal Investigator is unavailable or unable to continue the direction of the Research Program for a period in excess of thirty (30) days, UHN shall notify the Sponsor and may additionally nominate one or more replacements. If no replacement is nominated by UHN, or if no nominee is satisfactory to the Sponsor, the Sponsor may terminate this Agreement upon thirty (30) days notice to UHN.
Sample 1Sample 2Sample 3See All (4)
Replacement of Principal Investigator. In the event Principal Investigator becomes either unwilling or unable to perform the duties required by this Agreement, upon request by AIM, Institution will cooperate, in good faith and expeditiously, to find a replacement. The Institution’s cooperation in finding an acceptable replacement does not negate their obligations to perform this Agreement up to the effective date of termination.
Sample 1Sample 2
Replacement of Principal Investigator. If the Principal Investigator leaves the Institution or otherwise ceases to be available then: (a) the Institution must notify JDRF as soon as is practical; (b) the Institution must consult with JDRF and use reasonable endeavours to nominate as soon as practicable a replacement reasonably acceptable to both parties; and (c) if a replacement cannot be found who is acceptable to both parties, JDRF may require recruitment into the Study by the Institution to cease, and JDRF may terminate this agreement in accordance with clause 17(d).
Sample 1
Replacement of Principal Investigator. If the services of the Principal Investigator become unavailable to CSHL for any reason, CSHL will be entitled to designate another member of its faculty who is acceptable to both parties to serve as the Principal Investigator of the Sponsored Research.
Sample 1
Replacement of Principal Investigator. In the event the Principal Investigator becomes either unwilling or unable to perform the duties required by this Agreement Institution shall notify Sponsor in writing within ten (10) days, and Institution and Principal Investigator will cooperate, in good faith and expeditiously, to find a replacement investigator acceptable to Sponsor. In the event an acceptable substitute is not found, this Agreement may be terminated by any Party in accordance with Section 11 of this Agreement. Institution’s cooperation in finding an acceptable replacement investigator does not modify or alter its obligation to perform its obligations and duties pursuant to this Agreement. In the event of determination of a new principal investigator said new principal investigator shall sign documentation provided by Sponsor acknowledging his or her new duties as Principal Investigator and an amendment to the agreement will be concluded.
Sample 1
AutoNDA by SimpleDocs
Replacement of Principal Investigator. In the event the Principal Investigator becomes either unwilling or unable to perform the duties required by this Agreement 2.2
Sample 1

Related to Replacement of Principal Investigator

  • Principal Investigator The Research will be supervised by __________________ ("Principal Investigator"). If for any reason the individual is unable to continue to serve as Principal Investigator and a successor acceptable to both the University and the Sponsor is not available, this agreement shall be terminated as provided in Article 9. The Principal Investigator may work with others at the University (“Associates”) in conducting the Research.

  • Office of Inspector General Investigative Findings Expert Review In accordance with Senate Bill 799, Acts 2021, 87th Leg., R.S., if Texas Government Code, Section 531.102(m-1)(2) is applicable to this Contract, Contractor affirms that it possesses the necessary occupational licenses and experience.

  • Institution and Investigator acknowledge and agree that its, his or her judgment with respect to its, his or her advice to and care of each Subject is not and shall not be affected by the compensation Institution and/or Investigator receive in accordance with the Study.

  • Replacement of Key Personnel The Engineer must notify the State in writing as soon as possible, but no later than three business days after a project manager or other key personnel is removed from association with this contract, giving the reason for removal.

  • Independence of the Asset Representations Reviewer The Asset Representations Reviewer will be an independent contractor and will not be subject to the supervision of the Issuer for the manner in which it accomplishes the performance of its obligations under this Agreement. Unless expressly authorized by the Issuer, the Asset Representations Reviewer will have no authority to act for or represent the Issuer and will not be considered an agent of the Issuer. Nothing in this Agreement will make the Asset Representations Reviewer and the Issuer members of any partnership, joint venture or other separate entity or impose any liability as such on any of them.

  • Examination of Mortgage Loan Files and Due Diligence Review The Mortgage Loan Seller shall reasonably cooperate with any examination of the Mortgage Files for, and any other documents and records relating to, the Mortgage Loans, that may be undertaken by or on behalf of the Purchaser on or before the Closing Date. The fact that the Purchaser has conducted or has failed to conduct any partial or complete examination of any of the Mortgage Files for, and/or any of such other documents and records relating to, the Mortgage Loans, shall not affect the Purchaser’s right to pursue any remedy available in equity or at law for a breach of the Mortgage Loan Seller’s representations and warranties made pursuant to Section 4, except as expressly set forth in Section 5.

  • Independence of Asset Representations Reviewer The Asset Representations Reviewer will be an independent contractor and will not be subject to the supervision of the Issuer or the Owner Trustee for the manner in which it accomplishes the performance of its obligations under this Agreement. Unless authorized by the Issuer or the Owner Trustee, respectively, the Asset Representations Reviewer will have no authority to act for or represent the Issuer or the Owner Trustee and will not be considered an agent of the Issuer or the Owner Trustee. Nothing in this Agreement will make the Asset Representations Reviewer and either of the Issuer or the Owner Trustee members of any partnership, joint venture or other separate entity or impose any liability as such on any of them.

  • Drug-Free Workplace Certification As required by Executive Order No. 90-5 dated April 12, 1990, issued by the Governor of Indiana, the Company hereby covenants and agrees to make a good faith effort to provide and maintain a drug-free workplace at the Project Location. The Company will give written notice to the IEDC within ten (10) days after receiving actual notice that the Company, or an employee of the Company in the State of Indiana, has been convicted of a criminal drug violation occurring in the workplace. False certification or violation of this certification may result in sanctions including, but not limited to, suspension of payments under the Agreement, termination of the Agreement and/or debarment of contracting opportunities with the State for up to three (3) years. In addition to the provisions of the above paragraph, if the total amount set forth in the Agreement is in excess of $25,000.00, the Company agrees that it will provide a drug-free workplace by: A. Publishing and providing to all of its employees a statement notifying them that the unlawful manufacture, distribution, dispensing, possession or use of a controlled substance is prohibited in the Company’s workplace, and specifying the actions that will be taken against employees for violations of such prohibition;

  • Investigator Where a difference arises between the parties relating to the dismissal, discipline or suspension of an employee, or to the interpretation, application, operation or alleged violation of this agreement, including any questions as to whether a matter is arbitrable, during the term of the collective agreement, an arbitrator agreed to by the parties shall, at the request of either party: (a) investigate the difference; (b) define the issue in the difference; and (c) make written recommendations to resolve the difference within five days of the date of receipt of the request and for those five days from that date time does not run in respect of the grievance procedure. The parties agree that this procedure will not be invoked until the grievance procedure has been completed.

  • Lost Shareholder Due Diligence Searches and Servicing The Trust hereby acknowledges that USBFS has an arrangement with an outside vendor to conduct lost shareholder searches required by Rule 17Ad-17 under the Securities Exchange Act of 1934, as amended. Costs associated with such searches will be passed through to the Trust as an out-of-pocket expense in accordance with the fee schedule set forth in Exhibit C hereto. If a shareholder remains lost and the shareholder’s account unresolved after completion of the mandatory Rule 17Ad-17 search, the Trust hereby authorizes vendor to enter, at its discretion, into fee sharing arrangements with the lost shareholder (or such lost shareholder’s representative or executor) to conduct a more in-depth search in order to locate the lost shareholder before the shareholder’s assets escheat to the applicable state. The Trust hereby acknowledges that USBFS is not a party to these arrangements and does not receive any revenue sharing or other fees relating to these arrangements. Furthermore, the Trust hereby acknowledges that vendor may receive up to 35% of the lost shareholder’s assets as compensation for its efforts in locating the lost shareholder.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!